CDDS Makes a Difference

The Center for Drug Development Science (CDDS), established in late 1994 at Georgetown University and with the UCSF School of Pharmacy since October, 2004, seeks to advance the science, strategic planning, and management processes of drug development and to establish clinical drug development science as a rigorous academic discipline through four programs:

Research

Investigating contemporary drug development practices and evaluating and developing novel scientific methodologies.

Education

Contributing to the education of practitioners of drug and regulatory science.

Public Policy

Providing for a discussion of drug development science and regulatory policies.

Technical Assistance

Providing in-real-time assessment and guidance of drug development projects.

Publications

During the past years the center has:

• Established an understanding of contemporary drug development practices.
• Pioneered modeling and simulation of clinical trials.
• Trained over 19 scientists who now work at organizations including the FDA, the Ministry of Health and Welfare (MHW), and various pharmaceutical and bioscience companies.
• Influenced the FDA Modernization Act of 1997.
• Sponsored more than 15 conferences, workshops, and testimonies.
• Advised over 80 firms on a total of over 200 Investigational New Drug (IND) applications to the Food & Drug Administration (FDA).

Latest News

Improving Drug Development Using Patient Adherence Data in Clinical Trials, May 6-7, 2008.
Brochure (PDF)
Registration site

Advanced NONMEM workshop – March 17–19, 2008 at Mission Bay Conference Center, San Francisco, CA.
More information >

UCSF-CDDS to launch The American Course on Drug Development and Regulatory Science- September 2007
More information >

CDDS – Pharmacometric Services is available to drug researchers
More >

Howard Lee, MD, PhD, named Director of CDDS
More >

Lewis B. Sheiner Memorial. Symposium held at CDDS in December 2006
More >